Shares of Quotient Ltd (NASDAQ:QTNT) shot up 7.4% during trading on Thursday . The company traded as high as $5.73 and last traded at $5.52. 989,030 shares were traded during trading, an increase of 15% from the average session volume of 858,580 shares. The stock had previously closed at $5.14.
A number of research firms have recently commented on QTNT. BidaskClub downgraded Quotient from a “sell” rating to a “strong sell” rating in a report on Tuesday, September 1st. Zacks Investment Research downgraded Quotient from a “buy” rating to a “hold” rating in a report on Thursday. Finally, Jefferies Financial Group reiterated a “buy” rating and issued a $13.50 price target on shares of Quotient in a report on Wednesday, August 19th.
The stock has a market capitalization of $445.15 million, a price-to-earnings ratio of -3.91 and a beta of 2.40. The company has a debt-to-equity ratio of 9.74, a quick ratio of 3.77 and a current ratio of 4.54. The firm has a fifty day moving average of $5.46 and a 200-day moving average of $6.49.
In other news, major shareholder Perceptive Advisors Llc acquired 2,911,764 shares of the firm’s stock in a transaction on Tuesday, September 15th. The stock was bought at an average cost of $4.25 per share, with a total value of $12,374,997.00. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Corporate insiders own 12.30% of the company’s stock.
Large investors have recently bought and sold shares of the business. Bank of Montreal Can bought a new position in shares of Quotient during the second quarter worth about $37,000. Paloma Partners Management Co bought a new position in shares of Quotient during the first quarter worth about $40,000. Ameritas Investment Partners Inc. bought a new position in shares of Quotient during the second quarter worth about $40,000. Royal Bank of Canada lifted its position in shares of Quotient by 32.5% during the first quarter. Royal Bank of Canada now owns 11,940 shares of the company’s stock worth $47,000 after purchasing an additional 2,932 shares during the last quarter. Finally, Blair William & Co. IL bought a new position in shares of Quotient during the second quarter worth about $74,000. 77.64% of the stock is owned by institutional investors.
Quotient Company Profile (NASDAQ:QTNT)
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, and commercializes conventional reagent products used for blood grouping in the transfusion diagnostics market worldwide. The company is developing MosaiQ, a proprietary technology platform, which provides tests for blood grouping and serological disease screening.
Featured Article: Initial Coin Offering (ICO)
Receive News & Ratings for Quotient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quotient and related companies with MarketBeat.com's FREE daily email newsletter.